Showing posts with label Odefsey (emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg or R/F/TAF). Show all posts
Showing posts with label Odefsey (emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg or R/F/TAF). Show all posts
Thursday, May 26, 2016

FDA Approves Odefsey (emtricitabine, rilpivirine and tenofovir alafenamide) for the Treatment of HIV-1 Infection

›
Gilead Sciences, Inc announced that the U.S. Food and Drug Administration (FDA) has approved  Odefsey  (emtricitabine 200 mg/rilpivirine 2...